Latest filing published 09 Oct 2026 for BioStem Technologies, Inc., €445k. Read the official filing
No signal scores available.
All filings by Vurst Andrew Smith-Van on record concern BioStem Technologies, Inc. We count 3 filings; the first trade dates from 15 September 2026 and the latest from 7 October 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 9 October 2026 with an option exercise (€445k) in BioStem Technologies, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations